Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trials benefit from acronyms

Executive Summary

Naming randomized trials with acronyms may enhance citation rate after publication, according to a study published in the July 6 issue of the New England Journal of Medicine. Acronym-named randomized trials published between 1953 and 2003 were cited at twice the rate of trials not named with acronyms. Trial acronyms may have subliminal influences "since specific acronyms could invoke subconscious value-laden associations that might enhance positive perceptions of the studies they name," study authors note...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047371

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel